Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

4,310.71p
   
  • Change Today:
    -14.29p
  • 52 Week High: 5,060.00
  • 52 Week Low: 3,500.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 100
  • Market Cap: £225.00m
  • Beta: 0.04

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
17.46% above the market average17.46% above the market average17.46% above the market average17.46% above the market average17.46% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average
1yr Revenue Growth
1.80% above the market average1.80% above the market average1.80% above the market average1.80% above the market average1.80% above the market average
21.21% above the sector average21.21% above the sector average21.21% above the sector average21.21% above the sector average21.21% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
2.46% below the market average2.46% below the market average2.46% below the market average2.46% below the market average2.46% below the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
1yr DPS Growth
62.74% above the market average62.74% above the market average62.74% above the market average62.74% above the market average62.74% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
54.17% above the market average54.17% above the market average54.17% above the market average54.17% above the market average54.17% above the market average
53.85% above the sector average53.85% above the sector average53.85% above the sector average53.85% above the sector average53.85% above the sector average
Price Book Ratio
96.11% below the market average96.11% below the market average96.11% below the market average96.11% below the market average96.11% below the market average
86.67% below the sector average86.67% below the sector average86.67% below the sector average86.67% below the sector average86.67% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
62.17% below the market average62.17% below the market average62.17% below the market average62.17% below the market average62.17% below the market average
16.36% below the sector average16.36% below the sector average16.36% below the sector average16.36% below the sector average16.36% below the sector average
Price Chg 3m
30.07% below the market average30.07% below the market average30.07% below the market average30.07% below the market average30.07% below the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
42.38% below the market average42.38% below the market average42.38% below the market average42.38% below the market average42.38% below the market average
32% below the sector average32% below the sector average32% below the sector average32% below the sector average32% below the sector average
Momentum 20
98.8% below the market average98.8% below the market average98.8% below the market average98.8% below the market average98.8% below the market average
96% below the sector average96% below the sector average96% below the sector average96% below the sector average96% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
75.00% above the market average75.00% above the market average75.00% above the market average75.00% above the market average75.00% above the market average
93.94% above the sector average93.94% above the sector average93.94% above the sector average93.94% above the sector average93.94% above the sector average
ROCE
80.07% above the market average80.07% above the market average80.07% above the market average80.07% above the market average80.07% above the market average
57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
92.56% above the market average92.56% above the market average92.56% above the market average92.56% above the market average92.56% above the market average
92.00% above the sector average92.00% above the sector average92.00% above the sector average92.00% above the sector average92.00% above the sector average
Forecast EPS
82.23% above the market average82.23% above the market average82.23% above the market average82.23% above the market average82.23% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
34.91% below the market average34.91% below the market average34.91% below the market average34.91% below the market average34.91% below the market average
9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average
Operating Profit Loss
29.01% above the market average29.01% above the market average29.01% above the market average29.01% above the market average29.01% above the market average
72.00% above the sector average72.00% above the sector average72.00% above the sector average72.00% above the sector average72.00% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
27.03% below the market average27.03% below the market average27.03% below the market average27.03% below the market average27.03% below the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average
Cash
13.93% below the market average13.93% below the market average13.93% below the market average13.93% below the market average13.93% below the market average
4% below the sector average4% below the sector average4% below the sector average4% below the sector average4% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
77.78% above the market average77.78% above the market average77.78% above the market average77.78% above the market average77.78% above the market average
80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average
Buys 1y
55.12% below the market average55.12% below the market average55.12% below the market average55.12% below the market average55.12% below the market average
79.31% below the sector average79.31% below the sector average79.31% below the sector average79.31% below the sector average79.31% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 4,310.71p
Change Today -14.29p
% Change -0.33 %
52 Week High 5,060.00
52 Week Low 3,500.00
Volume 100
Shares Issued 5.22m
Market Cap £225.00m
Beta 0.04

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
98.16% below the market average98.16% below the market average98.16% below the market average98.16% below the market average98.16% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
75.35% above the market average75.35% above the market average75.35% above the market average75.35% above the market average75.35% above the market average
92.73% above the sector average92.73% above the sector average92.73% above the sector average92.73% above the sector average92.73% above the sector average
Income
13.07% below the market average13.07% below the market average13.07% below the market average13.07% below the market average13.07% below the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average
Growth
33.48% below the market average33.48% below the market average33.48% below the market average33.48% below the market average33.48% below the market average
31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 11-Apr-24 09-Nov-23
Paid 26-Apr-24 24-Nov-23
Amount 68.00p 90.00p

Trades for 03-May-2024

Time Volume / Share Price
10:31 9 @ 4,325.00p
09:48 57 @ 4,325.00p
09:22 10 @ 4,325.00p
09:02 23 @ 4,325.00p
08:10 1 @ 4,341.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page